Comments
FDA cites risk, but MS patients seek unproven therapy
06.10.2012. | LOS ANGELES/NEW YORK (Reuters) - A controversial treatment for multiple sclerosis has been linked by U.S. health regulators to serious injuries including stroke, paralysis or even death, prompting them to issue an official warning to patients and physicians earlier this year....
